How lymphotoxic is doseIntensified temozolomide? The glioblastoma experience - Reply Journal Article

  

Authors:	Su, Y. B.; Krown, S. E.; Livingston, P. O.; Wolchok, J. D.; Chapman, P. B.
Article Title:	How lymphotoxic is doseIntensified temozolomide? The glioblastoma experience - Reply
Keywords:	drug dose comparison; drug efficacy; temozolomide; letter; t lymphocyte; melanoma; multiple cycle treatment; dexamethasone; pneumocystis pneumonia; risk factor; lymphocytopenia; glioblastoma; immunosuppressive treatment; opportunistic infection; esophagus candidiasis
Journal Title:	Journal of Clinical Oncology
Volume:	23
Issue:	18
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2005-06-01
Start Page:	4236
Language:	English
DOI:	10.1200/jco.2005.01.0579
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-33846803889&partnerID=40&md5=8229dabbd7abc4e98fb2e8e5d2ce273e
Notes:	--- - "Export Date: 24 October 2012" - "CODEN: JCOND" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/35941